Bringing the fundamentals into focus…
Back to Avalo Therapeutics, Inc.
How Avalo Therapeutics, Inc. stacks up
AVTX · against 406 other Healthcare companies of similar size
Profitability
5/ 100
Near the bottom of its peers.
Ranked #386 of 407 · scores higher than 4% of peers
Bars: peers in each 10-point band of the profitability score42 peers with a profitability score of 0–9, including AVTX · Click a bar to see the companies
Why profitability scores 5?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 100% of peers. Operating margin: -154847.5% vs peer median 7.1%
- a lower return on assets: weaker than 81% of peers. Return on assets: -20.4% vs peer median 1.7%
- a lower return on invested capital: weaker than 79% of peers. Return on invested capital: -19.9% vs peer median 4.7%
Metric by metric
Position: dot = AVTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AVTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 376 reported | -19.9% | 0.8% | 25% | 33% | |
| Operating marginHigher is better · 379 reported | -154847.5% | 3.4% | 1% | 33% | |
| Return on assetsHigher is better · 405 reported | -20.4% | 0.4% | 23% | 33% | |
| Return on equityHigher is better · 384 reported | -36.3% | -0.2% | 22% | Context only | |
| Gross marginHigher is better · 425 reported | 0.0% | 38.1% | 4% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around AVTX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 382 | 4.6B SEK (≈$462M) | 6 | 37 | |
| 382 | 354M USD | 6 | 13 | |
| 382 | 314M USD | 6 | 56 | |
| 386 | 397M USD | 5 | 37 | |
| 386 | 389M USD | 5 | 33 | |
| 386 | 274M USD | 5 | 57 | |
| 386 | 327M USD | 5 | 11 | |
| 386 | 215M USD | 5 | 34 | |
| 386 | 469M USD | 5 | 45 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score